AccScience Publishing / MI / Online First / DOI: 10.36922/mi.5189
CASE REPORT

Primary cutaneous nocardiosis due to Nocardia farcinica in an immunocompetent patient: A case report

Maya Polashenski1* Olga Vasylyeva1
Show Less
1 Department of Infectious Disease, Rochester General Hospital, 1425 Portland Ave, Rochester, New York, United States of America
Submitted: 17 October 2024 | Revised: 30 November 2024 | Accepted: 9 December 2024 | Published: 31 December 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Nocardia is an opportunistic pathogen that can present as pulmonary, central nervous system, or disseminated infection in immunocompromised host. However, primary cutaneous Nocardia infections have distinctive presentations in immunocompetent hosts. When infecting a host with an intact immune system, the infection tends to be more insidious, delaying accurate diagnosis and leading to inadequate treatment and persistent infection. Herein, we present a rare case of post-operative cutaneous nocardiosis in a 57-year-old immunocompetent patient with a delay in therapy resulting in a prolonged non-healing wound. Nineteen case reports were reviewed to identify trends in immune status, exposure, treatment regimens, and responses to therapy in both immunocompromised and immunocompetent patients with Nocardia farcinica cutaneous infection. This case report summarizes characteristics of patient populations where N. farcinica might be suspected and emphasizes the importance of a thorough environmental and occupational history in the case of immunocompetent patients. It also addresses challenges in the treatment of cutaneous N. farcinica as related to empiric therapy, antibiotic resistance, and duration of treatment, ultimately providing an algorithm to approach the management of primary cutaneous nocardiosis.

Keywords
Postoperative infection
Actinomycete
Nocardiosis
Nocardia farcinica
Primary cutaneous nocardiosis
Funding
None.
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Fatahi-Bafghi M. Nocardiosis from 1888 to 2017. Microb Pathog. 2018;114:369-384. doi: 10.1016/j.micpath.2017.11.012

 

  1. Gao S, Liu Q, Zhou X, Dai X, He H. Primary cutaneous nocardiosis due to Nocardia farcinica: A case report of an often overlooked infection. Infect Drug Resist. 2021;14:1435-1440. doi: 10.2147/IDR.S306161

 

  1. Wilson JW. Nocardiosis: Updates and clinical overview. Mayo Clin Proc. 2012;87(4):403-407. doi: 10.1016/j.mayocp.2011.11.016

 

  1. Rawat D, Rajasurya V, Chakraborty RK, Sharma S. Nocardiosis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.

 

  1. Hemmersbach-Miller M, Stout JE, Woodworth MH, Cox GM, Saullo JL. Nocardia infections in the transplanted host. Transpl Infect Dis. 2018;20(4):e12902. doi: 10.1111/tid.12902

 

  1. Merinopoulos D, Khan H, Ginwalla S, Lane S, Watts R. Nocardia farcinica complicating Cogan’s syndrome. Oxf Med Case Reports. 2014;2014(2):36-38. doi: 10.1093/omcr/omu016

 

  1. Auzary C, Mouthon L, Soilleux M, Cohen P, Boiron P, Guillevin L. Localized subcutaneous Nocardia farcinica abscess in a woman with overlap syndrome between systemic scleroderma and polymyositis. Ann Med Interne (Paris). 1999;150(7):582-584.

 

  1. Yokota S, Kawabe K, Yamada H, Nunomura M. Case of subcutaneous abscess caused by Nocardia farcinica in an aplastic anemia patient. Nihon Ishinkin Gakkai Zasshi. 2010;51(2):93-97. doi: 10.3314/jjmm.51.93

 

  1. Granier F, Kahla-Clémenceau N, Richardin F, et al. Nocardia farcinica infection. Cutaneous form in an immunodepressed patient. Presse Med. 1994;23(7):329-331.

 

  1. De Nardo P, Giancola ML, Noto S, et al. Left thigh phlegmon caused by Nocardia farcinica identified by 16S rRNA sequencing in a patient with leprosy: A case report. BMC Infect Dis. 2013;13:162. doi: 10.1186/1471-2334-13-162

 

  1. Malani AK, Gupta C, Weigand RT, Gupta V, Rangineni S. Thigh abscess due to Nocardia farcinica. J Natl Med Assoc. 2006;98(6):977-979.

 

  1. Torres OH, Domingo P, Pericas R, Boiron P, Montiel JA, Vázquez G. Infection caused by Nocardia farcinica: Case report and review. Eur J Clin Microbiol Infect Dis. 2000;19(3):205-212. doi: 10.1007/s100960050460

 

  1. Angeles RM, Lasala RP, Fanning CV. Disseminated subcutaneous nocardiosis caused by Nocardia farcinica diagnosed by FNA biopsy and 16S ribosomal gene sequencing. Diagn Cytopathol. 2008;36(4):266-269. doi: 10.1002/dc.20804

 

  1. Zhu N, Zhu Y, Wang Y, Dong S. Pulmonary and cutaneous infection caused by Nocardia farcinica in a patient with nephrotic syndrome: A case report. Medicine (Baltimore). 2017;96(24):e7211. doi: 10.1097/MD.0000000000007211

 

  1. Rees W, Schüler S, Hummel M, Hetzer R. Primär kutane Nocardia-farcinica-infektion nach herztransplantation. [Primary cutaneous Nocardia farcinica infection following heart transplantation]. [Published correction appears in Dtsch Med Wochenschr. 1994;119(45):1568]. Dtsch Med Wochenschr. 1994;119(38):1276-1280. doi: 10.1055/s-2008-1058833

 

  1. Ghandour M, Shereef H, Homida H, Revankar S, Zachariah MS. Disseminated nocardiosis in a renal transplant recipient. Cureus. 2021;13(1):e12497. doi: 10.7759/cureus.12497

 

  1. Schiff TA, McNeil MM, Brown JM. Cutaneous Nocardia farcinica infection in a nonimmunocompromised patient: Case report and review. Clin Infect Dis. 1993;16(6):756-760. doi: 10.1093/clind/16.6.756

 

  1. Bosamiya SS, Vaishnani JB, Momin AM. Sporotrichoid nocardiosis with cutaneous dissemination. Indian J Dermatol Venereol Leprol. 2011;77(4):535. doi: 10.4103/0378-6323.82409

 

  1. Acuner B, Cömert F. Recurrent subcutaneous abscess due to Nocardia farcinica in an immunocompetent patient: A case report. Wound Manag Prev. 2021;67(5):33-39.

 

  1. McTaggart LR, Doucet J, Witkowska M, Richardson SE. Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis. Antimicrob Agents Chemother. 2015;59(1):269-275. doi: 10.1128/AAC.02770-14

 

  1. Zhao P, Zhang X, Du, P, Li G, Li L, Li Z. Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay. Sci Rep. 2017;7:43660. doi: 10.1038/srep43660

 

  1. Margalit I, Lebeaux D, Tishler O, et al. How do I manage nocardiosis? Clin Microbiol Infect. 2021;27(4):550-558. doi: 10.1016/j.cmi.2020.12.019

 

  1. Lao CK, Tseng MC, Chiu CH, et al. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020. J Formos Med Assoc. 2022;121(10):2109-2122. doi: 10.1016/j.jfma.2022.06.011

 

  1. Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and Laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259-282. doi: 10.1128/cmr.19.2.259-282.2006
Share
Back to top
Microbes & Immunity, Electronic ISSN: 3029-2883 Print ISSN: 3041-0886, Published by AccScience Publishing